The pharmaceutical industry is facing significant concerns about their future revenue growth.
This is compounded with heightened regulatory scrutiny, a dearth of product approvals, mounting payer demands for product performance and increasing pricing pressure.
Increased focus on healthcare economics is essential for companies to succeed owing to
increasing budgetary demands, a growing population longevity and the mounting burden of chronic disease; all of these factors place further stresses on healthcare systems leading to increased activism by payers who are insisting on tighter product performance criteria before funding new treatments.
Suggestions on how to maximise revenue growth in the short term:
PwC’s services help to identify future growth opportunities and implement strategies
PwC offers a wide array of services to help pharmaceutical, biotech, medical-device, generics and service provider companies identify future growth opportunities and implement strategies, processes and structures to achieve that growth.
Our team will assist you in defining your strategy and business plans as you meet the challenges of a changing environment.